Multiomics integration: advancing pediatric cancer immunotherapy

Lauren Coyle, Editor, Immuno-Oncology Insights, speaks with Raoul Santiago, Clinical Investigator and Associate Professor of Pediatric Hematology and Oncology, University Hospital Center, Laval University, to discuss the role of multiomics in the I-O setting and how these tools can be leveraged to improve pediatric cancer care.

Chapters

• 1:02 Can you tell us a bit about your current role and the work that you do?
• 1:52 Could you tell us more about how you apply these multiomic approaches in your work and what the cutting edge in the area is for you?
• 4:44 What impact are these tools having on our understanding of the immune response/immunotherapy approaches to cancer?
• 9:42 What progress do you see being made in the ongoing search for novel biomarkers in the I-O space, and what will be the keys to their successful deployment?
• 11:40 What should be the next specific targets for the oncology field in terms of further improving our knowledge of the underlying biology of the immune response/tumor microenvironment? What tools will be key in achieving success in these efforts?
• 13:04 What would be top of your wish list for new innovations in this space?
• 15:57 What will be your own key goals and priorities in the next few years?